ArticleJournal of neurology2025
Olfactory identification impairment in cerebral small-vessel disease indicates cognitive network disconnection and predicts accelerated cognitive decline.
Article in Journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Olfactory dysfunction and increased systemic immune inflammation index in patients with atrial fibrillation.Biomolecules & biomedicine · 2026Article
- A new paradigm for stratified cognitive assessment: fusing serum Raman spectroscopy and ensemble learning.Alzheimer's research & therapy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundOlfactory identification impairment is a well-established early screening index for cognitive decline in neurodegenerative disorders. However, whether this simple sensory test can similarly detect or predict cognitive deficits in cerebral small vessel disease (CSVD)-a leading cause of vascular cognitive impairment-remains unclear.
methodsAll participants-including 193 CSVD patients and 164 normal controls (NC)-completed the University of Pennsylvania Smell Identification Test (UPSIT) and a comprehensive neuropsychological battery. Multimodal MRI analyses were conducted to identify structural and functional abnormalities associated with UPSIT performance. A cognitive follow-up assessment was performed 24 months post-baseline, and the rate of cognitive decline was annualized.
resultsCompared to NC, CSVD patients exhibited significantly lower UPSIT scores (p < 0.001). UPSIT performance correlated strongly with cognition. Local structural and functional abnormalities in primary and secondary olfactory cortices did not reliably predict UPSIT performance in CSVD patients. In contrast, dorsolateral prefrontal cortex functional connectivity strength was significantly associated with odor-identification performance. Mediation models further demonstrated that greater white matter lesion burden indirectly impaired olfactory identification via disrupted inter-network connectivity between the salience network (SN) and posterior default mode network (pDMN). CSVD patients with baseline UPSIT < 20 exhibited a steeper annual MMSE decline than those with UPSIT ≥ 20 (1.0 vs. 0.5 points per year; p < 0.001).
conclusionOlfactory identification impairment in patients with CSVD reflects disruption of higher-order cognitive networks, and a baseline UPSIT score below 20 predicts accelerated cognitive decline.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.